The combination of WT1 and p53 can be used to distinguish serous carcinoma from endometrioid carcinoma, while the combination of WT1, Napsin A and ER are used to distinguish clear-cell carcinoma from serous carcinoma. This evidence concerns the gene WT1 and serous adenocarcinoma.